Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, recently presented data from the company’s prospective, multi-center, randomized, crossover study (NILE – NCT04908254) comparing Dayspring®, the company’s active compression treatment for lymphedema, to a traditional pneumatic compression pump. In the trial, study participants reported significantly greater adherence to Dayspring treatment in comparison to the use of pneumatic compression pump. Additionally, subjects in the Dayspring arm demonstrated greater reduction in limb volume, improvement in quality of life and patient preference. Dayspring is the first active compression treatment that enables movement and mobility cleared by the U.S. Food & Drug Administration (FDA) to treat lymphedema and other similar…
